BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9045279)

  • 1. [Is white-coat hypertension a disease?].
    Bloch A
    Praxis (Bern 1994); 1997 Jan; 86(1-2):6-8. PubMed ID: 9045279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White-coat hypertension in adults and children.
    Verdecchia P
    Blood Press Monit; 1999; 4(3-4):175-9. PubMed ID: 10490871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White coat hypertension in treated hypertensives: a three year follow-up study.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    Can J Cardiovasc Nurs; 2003; 13(2):24-9. PubMed ID: 12802835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. True resistant hypertension: is it possible to be recognized in the office?
    Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
    Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
    Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [White coat hypertension].
    Lantelme P; Milon H
    Arch Mal Coeur Vaiss; 2000 Dec; 93(12):1534-40. PubMed ID: 11211449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mean platelet volume in patients with essential and white coat hypertension.
    Coban E; Yazicioglu G; Berkant Avci A; Akcit F
    Platelets; 2005 Nov; 16(7):435-8. PubMed ID: 16236605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
    Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
    Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients.
    Fogari R; Corradi L; Zoppi A; Lusardi P; Poletti L
    Blood Press Monit; 1996 Feb; 1(1):51-54. PubMed ID: 10226202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White coat effect, blood pressure and mortality in men: prospective cohort study.
    Strandberg TE; Salomaa V
    Eur Heart J; 2000 Oct; 21(20):1714-8. PubMed ID: 11032699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
    Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ
    Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
    Conen D; Dieterle T; Utech K; Rimner M; Martina B
    Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stress-associated hypertension in the work place: results of the STARLET project].
    Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
    Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
    Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
    J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["White-coat hypertension": variation of normality or of hypertension?].
    Carmona J; Amado P; Vasconcelos N; Santos I; Pinto C; Forte G; Arsénio A; Nazaré J
    Rev Port Cardiol; 1998 Jun; 17(6):505-12. PubMed ID: 9677828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study.
    Ugajin T; Hozawa A; Ohkubo T; Asayama K; Kikuya M; Obara T; Metoki H; Hoshi H; Hashimoto J; Totsune K; Satoh H; Tsuji I; Imai Y
    Arch Intern Med; 2005 Jul; 165(13):1541-6. PubMed ID: 16009871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.